Cognition Therapeutics, Inc.CGTXNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank20
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
-76.17%
Near historical average
Percentile
P20
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-81.06%
Historical baseline
PeriodValue
2024-76.17%
202313.57%
2022-411.32%
2021-6.24%
2020-6.20%
20190.00%